PFG
45
3
BA
54
5
XYL
49
4
PBI
69
4
LH
43
-2
VNO
60
10
CTSH
56
2
EXC
53
-3
UNP
52
7
LLY
37
-3
ROP
62
3
ROK
62
15
VRSN
53
-4
HAS
33
3
LEG
36
4
EQIX
64
2
BWA
48
2
UA
50
-9
LMT
34
2
KHC
24
13
PFG
45
3
BA
54
5
XYL
49
4
PBI
69
4
LH
43
-2
VNO
60
10
CTSH
56
2
EXC
53
-3
UNP
52
7
LLY
37
-3
ROP
62
3
ROK
62
15
VRSN
53
-4
HAS
33
3
LEG
36
4
EQIX
64
2
BWA
48
2
UA
50
-9
LMT
34
2
KHC
24
13
Financhill
Back

AIM ImmunoTech 10K Form

Sell
30

AIM
AIM ImmunoTech

Last Price:
0.21
Seasonality Move:
1.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-05-17 10Q AIM/AIM ImmunoTech Quarterly
2021-03-31 10K AIM/AIM ImmunoTech Annual
2020-11-12 10Q AIM/AIM ImmunoTech Quarterly
2020-08-14 10Q AIM/AIM ImmunoTech Quarterly
2020-05-14 10Q AIM/AIM ImmunoTech Quarterly
2020-03-30 10K AIM/AIM ImmunoTech Annual

Receive AIM News And Ratings

See the #1 stock for the next 7 days that we like better than AIM

AIM Financial Statistics

Sales & Book Value

Annual Sales: $202K
Cash Flow: $-3.27M
Price / Cash Flow: 0
Annual Sales: $0.05
Price / Book: 4.6

Profitability

EPS (TTM): -0.47000
Net Income (TTM): $-23.93M
Gross Margin: $160K
Return on Equity: -256.33%
Return on Assets: -129.02%

AIM ImmunoTech Earnings Forecast

Key AIM ImmunoTech Financial Ratios

  • The Gross Profit Margin over the past 29 years for AIM is 79.21%.
  • The Selling, General & Administrative Expenses for AIM have been equal to 10,463.86% of Gross Profit Margin.
  • The Research & Development expenses have been 5,415.35% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of AIM is -14,337.62% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 17 years.

AIM ImmunoTech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AIM
CUSIP: 00901B
Website: aimimmuno.com

Debt

Debt-to-Equity Ratio: 0.94
Current Ratio: 0.75
Quick Ratio: 0.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AIM Technical Analysis vs Fundamental Analysis

Sell
30
AIM ImmunoTech (AIM) is a Sell

Is AIM ImmunoTech a Buy or a Sell?

  • AIM ImmunoTech stock is rated a Sell
    The current AIM ImmunoTech [AIM] share price is $0.21. The Score for AIM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.